We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Hologic and Aloka Announce Distribution Agreement

By HospiMedica staff writers
Posted on 26 Nov 2003
Print article
A three-year distribution agreement gives Hologic (Bedford, MA, USA) exclusive distribution rights in the United States to ultrasound products for breast imaging to be manufactured by Aloka Company Ltd. (Tokyo, Japan) and customized to Hologic's specifications.

According to the agreement, Aloka will manufacture a joint-label, high-performance, fully functional diagnostic ultrasound system optimized for women's imaging, with emphasis on finding and diagnosing abnormalities within the breast. The system will incorporate Aloka's proprietary ProSound technologies, including digital pure beam imaging, tissue harmonic echo, 3D color Doppler, a 12-bit analog-to-digital converter to enable higher contrast resolution, and an integrated DICOM compatible image management.

"Our system specifications focused on the highest image quality, a versatile feature-set, simplicity of use for technologists and physicians, and affordable pricing for women's imaging suites that are suffering from overall reimbursement pressures,” said Jack Cumming, chairman and CEO of Hologic. "In addition and most importantly, Aloka shares our passion for improving healthcare for women.”




Related Links:
Hologic
Aloka
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Stereotactic QA Phantom
StereoPHAN
New
HF Stationary X-Ray Machine
TR20G

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.